
EVP, Chief Legal Officer · Tempus AI, Inc. · Class A Common Stock
Open-market sale
$654K reported value · 7.9% of prior position
Disclosed 0 business days after execution (deadline: 2)
Routine: 8 prior trades recorded in this security
3 other actors traded the same direction within 14 days
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Fukushima RyanCEO, Data | Grant or award · 10b5-1 plan | A | — 100.0K sh | Nov 4, 2026 traded Nov 2, 2026 | |
| 10 | Epstein David RDirector | Open-market sale · 10b5-1 plan | SELL | $27K 370 sh | Nov 4, 2026 traded Nov 2, 2026 | |
| 3 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $5,943 80 sh | Nov 4, 2026 traded Nov 2, 2026 | |
| 23 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $874K 10.3K sh | Sep 29, 2026 traded Sep 25, 2026 | |
| 26 | Bartolucci Ryan MChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $530K 7,062 sh | Sep 18, 2026 traded Sep 17, 2026 | |
| 16 | Polovin AndrewEVP, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $221K 2,951 sh | Sep 18, 2026 traded Sep 17, 2026 | |
| 13 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $49K 700 sh | Sep 18, 2026 traded Sep 16, 2026 | |
| 20 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $65K 1,000 sh | Sep 3, 2026 traded Sep 1, 2026 | |
| 27 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $683K 10.9K sh | Sep 3, 2026 traded Sep 1, 2026 | |
| 27 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $376K 5,900 sh | Sep 3, 2026 traded Sep 1, 2026 | |
| 27 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $810K 13.0K sh | Sep 3, 2026 traded Sep 1, 2026 | |
| 27 | West NadjaDirector | Open-market sale · 10b5-1 plan | SELL | $207K 3,000 sh | Sep 1, 2026 traded Aug 28, 2026 | |
| 30 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $1.00M 14.3K sh | Aug 25, 2026 traded Aug 21, 2026 | |
| 16 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $189K 2,694 sh | Aug 25, 2026 traded Aug 21, 2026 | |
| 16 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $29K 500 sh | Aug 20, 2026 traded Aug 19, 2026 | |
| 26 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $458K 9,232 sh | Aug 20, 2026 traded Aug 18, 2026 | |
| 23 | Polovin AndrewEVP, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $444K 7,927 sh | Aug 20, 2026 traded Aug 19, 2026 | |
| 19 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $173K 3,094 sh | Aug 20, 2026 traded Aug 19, 2026 | |
| 26 | Rogers James WilliamChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $1.58M 26.3K sh | Aug 20, 2026 traded Aug 19, 2026 | |
| 19 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $180K 2,994 sh | Aug 20, 2026 traded Aug 19, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $654,195
Polovin Andrew filed this Form 4 reporting a open-market sale of TEM on Feb 20, 2026. It became public on Feb 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.